|
Volumn 2014, Issue , 2014, Pages 186212-
|
Adoptive TIL transfer in the adjuvant setting for melanoma: long-term patient survival
a a a a a a a a a
a
HÔTEL DIEU
(France)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
ADOPTIVE IMMUNOTHERAPY;
ADVERSE EFFECTS;
CANCER STAGING;
FOLLOW UP;
GENETICS;
HUMAN;
IMMUNOLOGY;
IMMUNOPHENOTYPING;
MELANOMA;
METABOLISM;
MORTALITY;
PATHOLOGY;
PHENOTYPE;
TREATMENT OUTCOME;
TUMOR ASSOCIATED LEUKOCYTE;
BIOLOGICAL MARKERS;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOPHENOTYPING;
IMMUNOTHERAPY, ADOPTIVE;
LYMPHOCYTES, TUMOR-INFILTRATING;
MELANOMA;
NEOPLASM STAGING;
PHENOTYPE;
TREATMENT OUTCOME;
|
EID: 84922309315
PISSN: None
EISSN: 23147156
Source Type: Journal
DOI: 10.1155/2014/186212 Document Type: Article |
Times cited : (30)
|
References (0)
|